| 3 V Asset Management |
| 3i |
| 4SC |
| Abingworth |
| Ablynx |
| ABN Amro |
| ABN AMRO Capital Life Sciences |
| ABN AMRO Rothschild |
| Accelsiors Group |
| ACE BioSciences |
| Actelion |
| Adamant Biomedical Investments |
| ADVENTRX Pharmaceuticals |
| Adveq Management |
| Agendia |
| AGF Private Equity |
| AKALPA, Toder & Partner in Lifesciences |
| AKonsult |
| ALCIMED |
| ALLIGATOR bioscience |
| Alta Berkeley |
| Alta Partners |
| Amarin Corporation |
| Apeiron Biologics |
| Apoxis |
| Aravis Venture |
| Archimedes Pharma Limited |
| Astex Therapeutics |
| Athenagen |
| Athenagen |
| Atila Ventures |
| Atlas Venture |
| B.R.A.I.N |
| BankInvest |
| Bay City Capital |
| BB Biotech |
| BB Medtech |
| BHF Bank |
| BioConnect |
| Biogen Idec |
| BioGeneration |
| BioLauncher |
| Bio-M |
| BioMedinvest |
| Biomedpark Medien |
| BioMS Medical |
| Bionomics |
| Bionor Immuno |
| BioPartners |
| BioRexis |
| Biotechnology Management |
| BioTissue Technologies |
| BioTissue Technologies |
| BioValley Basel and ECPM |
| Biovertis |
| BioXell |
| Breslin |
| Canaccord Adams |
| Canadian Embassy |
| Canadian Embassy (Trade & Investment
Division) |
| CapMan |
| CBR Privatinvest |
| CDC Entreprises Innovation |
| Cellectis |
| Cellerix |
| Cellerix |
| CeNeS |
| CENiMED |
| Cerimon |
| ChemCon |
| Citigate Dewe Rogerson GmbH |
| Coller Capital |
| Comentum Advisors |
| Consulting in Biotechnology |
| Cornell Capital Partners |
| Credit Suisse |
| Cylene Pharmaceuticals |
| Cytos Biotechnology |
| DanioLabs |
| DebioPharm |
| Deutsche Bank |
| Dow Jones Newswires |
| Dr Rentschler Holding |
| DyoDelta Biosciences |
| Earlybird Venture Capital |
| East Hill Management Company |
| Economic Development Canton of Zurich |
| Edmond de Rothschild Investment Partners |
| EFG Bank |
| EMBL Ventures |
| Endoart |
| EQUI.TS |
| Equitech |
| Equity Development |
| Ernst & Young |
| ESBATech |
| Esprit Capital Partners |
| ETNA |
| European Venture Partners |
| EvaluatePharma |
| Evolutec |
| EyeSense |
| F. Hoffmann-La Roche |
| Faculties of Medicine of Geneva & Pittsburgh |
| FaustPharmaceuticals |
| Ferghana Partners |
| FHR Consult |
| FIBREX Medical |
| Financial Analyst, Member of the SFAF |
| Finanz und Wirtschaft |
| FIT Biotech Oyj |
| f-star Biotech |
| Future Capital |
| Gammacan |
| Genevest Consulting |
| Genomatix Software |
| Geratherm Medical |
| Geratherm Medical |
| Global Life Science Ventures |
| GLYCART Biotechnology |
| GLYCOTOPE |
| GlycoVaxyn |
| GlycoVaxyn |
| Greater Zurich Area |
| Handelszeitung |
| HBM Partners |
| Heidelberg Innovation |
| Helsinn Healthcare |
| Helvea |
| Helvea |
| High Tech Private Equity |
| High-Tech Gründerfonds Management |
| immatics biotechnologies |
| Incentive Asset Management |
| Independent Advisor |
| Index Ventures |
| ING Bank |
| InnovationsKapital |
| Innovator Capital |
| Insight Consulting |
| Institute of Brain Research |
| Intercell |
| Investment New Zealand |
| IsoTis OrthoBiologics |
| Jennings Capital |
| Journalist |
| JP Morgan |
| Katan Associates |
| Kepler Equities |
| Kuros Biosurgery |
| Lehman Brothers |
| Life Science & Financing Advisory |
| LifeCycle Pharma |
| MC Services |
| Med Services Europe |
| Medical Enzymes |
| MediGene |
| Medtronic Europe |
| MedWork |
| Mellon Financial Centre |
| Microcomponents |
| Mirabaud Asset Management |
| Molecular Partners |
| mondoBIOTECH |
| Moonstone Investment Management |
| Mummert & Company |
| MVM Life Science Partners |
| Nabriva Therapeutics |
| Natimmune |
| Neomed Management |
| Neovacs |
| Neue Zurcher Bank |
| Neurotune |
| NextGen Sciences |
| NGN Capital |
| NiKem Research |
| Nomura Code Securities |
| Northbank Communications |
| Novartis Pharma |
| Novartis Pharmaceuticals |
| Novartis Venture Fund |
| NovImmune |
| NOXXON Pharma |
| Nuevolution |
| Oakes, Lyman & Co |
| Objective Capital |
| Oneph\rm |
| OphthalmoPharma |
| Oridion Systems |
| Osprey Capital Partners |
| Oxford Genome Sciences |
| Oxford Immunotec |
| Oxxon Therapeutics |
| OZ Bankers |
| P&P Private Bank |
| Paramount BioCapital |
| Paul Capital Partners |
| PEPPERMINT Financial Partners |
| Peptech |
| Petercam Capital |
| Pevion Biotech |
| PharmaVentures |
| Phylogica |
| PIERIS Proteolab |
| Plethora Solutions |
| PolyMedix |
| Polyphor |
| PolyTechnos |
| Precimed |
| Pricewaterhousecoopers |
| Private Equity Invest |
| Privateq Advisors |
| ProMetic Biosciences |
| ProMetic Life Sciences |
| ProtAffin Biotechnologie |
| Protox Therapeutics |
| pSivida |
| Puilaetco Private Bankers |
| Quester Capital Management |
| R&D Focus - IMS Health |
| Remaco Merger |
| ReNeuron |
| Rentschler Holding |
| Reuters |
| RiboVax Biotechnologies |
| Rochat & Partners |
| Rosenow Grob Schilling |
| Rüd, Blass & Cie |
| Rüd, Blass & Cie |
| Ruston Poole |
| Sal. Oppenheim Jr. & Cie |
| Santaris Pharma |
| Savoy Investment Management |
| Schweizerhall Management |
| Scil Technology |
| Scottish Equity Partners |
| Scottish Widows Investment Partnership |
| Sectoral Asset Management |
| SEED |
| Seinagen |
| SG Securities |
| SGX Pharmaceuticals |
| Sherbrook Capital Management |
| Shire Pharmaceuticals |
| Siegfried Biologics |
| Signature Diagnostics |
| Sinclair Pharma |
| Sirtris Pharmaceuticals |
| Sitka |
| Sofinnova Partners |
| South East Growth Fund |
| Speedel |
| SPEF Venture |
| Stierli Investor Relations |
| Stratos Bio |
| SuppreMol |
| Suterscience |
| SV Life Sciences |
| Swiss Equity Magazine |
| Swiss Re Private Equity Advisors |
| SWX Swiss Exchange |
| Syngenta |
| Tamedia AG - Tages Anzeiger |
| Target BioScience |
| Tech Investor |
| The BioScience Ventures Group |
| The Trout Group |
| TiGenix |
| Tolxdorff & Eicher Consulting |
| Top Technology Ventures |
| TopoTarget |
| Truffle Venture |
| TVM Capital |
| UBS Global Asset Management |
| UBS Investment Bank |
| Van der Geest PR & Consulting |
| Vectura |
| Ventaira Pharmaceuticals |
| Venture Associates |
| Venture Valuation |
| VI Partners |
| Virax Holdings |
| Warburg Pincus |
| Wellington Partners Venture Capital |
| WestLB |
| Widmann Associates |
| Wilshire Private Markets |
| Wolf Research & Asset Management |
| XOMA |
| Xytis Pharmaceuticals |
| YM BioSciences |
| Z-Cube |
| Zimmer |